Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Wo Wu Biological: First Subject Enrolled in Phase II Clinical Trial of House Dust Mite Membrane Agent
Wo Wu Biologics announced that the first participant has been enrolled in the affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, for the clinical study evaluating the efficacy and safety of the company’s R&D product “House Dust Mite Membrane Preparation,” administered sublingually, in Chinese adult patients with dust mite allergic rhinitis— a randomized, double-blind, placebo-controlled Phase II clinical trial— and the study has officially entered the clinical trial phase.